Summary.-The peripheral blood lymphocyte count has been measured in 74 cases of histologically proven carcinoma of the gastrointestinal tract. The count has been correlated with the pathological stage of tumour spread and the patient's delayed hypersensitivity response to 2.4 dinitrochlorobenzene (DNCB). A statistically significant correlation was found between the peripheral blood lymphocyte count and the response to DNCB. There was linear association between the extent of spread of the tumours and the lymphocyte count. Those patients with low peripheral blood lymphocyte counts tended to have more advanced tumours and a poor response to DNCB. The possible causes of this lymphopenia are discussed.
TREATMENT of gastrointestinal cancer has been disappointing, in that despite more aggressive and radical surgical techniques there has been no concomitant improvement in survival figures. This has stimulated a search for adjuvant forms of therapy which will assist in the eradication of malignant cells from the body. Much interest has been concentrated on the possible role of immunotherapy. This interest has been accentuated by the demonstration of peripheral blood lymphocyte induced tumour cell killing. This may be due to the presence of tumour specific transplantation antigens (Hellstr6m et al., 1971) . It has been suggested that these antigens may be able to excite an immune response in the host. which will in turn restrict the proliferation of the tumour (Morton, 1972) . Cellular immunity is believed to be the more important factor in the immune response to neoplasia and a relationship between cellular immunity and prognosis has been demonstrated in patients with gastrointestinal cancer (Bone, Appleton and Venables, 1973) . The small lymphocvte has a very important role in the cellular immune response in the homograft reaction and in the response to malignant disease. Sensitized cells have been shown to have a cytotoxic effect on malignant cells in vitro (Hellstr6m and Hellstrom, 1970) . Attempts at adoptive immunization by infusing sensitized lymphocvtes into tumour bearing patients have shown that it is possible to obtain some degree of remission of the disease (Woodruff and Nolan. 1963: Symes, Riddell and Immelman, 1968 ).
This present investigation was designed to study the relationship of cellular immunity to the peripheral blood lymphocyte count in patients with gastrointestinal cancer.
MATERIALS AND METHODS
Patients-.Seventy-four patients with histologically proven carcinoma of the gastrointestinal tract were studied. Table I shows Figure 1 shows the distribution of the responses to DNCB in the patients with malignant disease. Although 25O% were anergic. a high proportion of these patients (400h) showed a good response. i.e. Crade IV. Previous workers have reported the ability to sensitize up to 950/ of a normal population (Eilber and AMorton. 1970) . and this has been confirmed in 20 control patients who had their DNCB responses assessed (Fig. 2) . Figure 3 shows the distribution of Figure 4 shows the relationship of peripheral blood lymphocyte count with the DNCB grading in patients with malignant disease. The mean lymphocyte count increased with increasing sensitivitv to DNCB. This is a statistically highly significant relationship (P < 0.001) and the difference in mean lymphocyte count for the 4 DNCB grades is ascribable to a linear trend by analysis of variance (P < 0-001).
The relationship of lymphocyte count to DNCB grading is given approximately bv the formula: 
DISC1USSION
This study has demonstrated a statistically significant relationship between malignant disease of the gastrointestinal tract and a depressed delayed hypersensitivity (DH) response to DNCB. This depression of the DH response is in turn statistically correlated with a reduction in the number of circulating peripheral blood lymphocytes. The depression of the DH response to DNCB in cancer patients is well recognized Krant et al.. 1968 ). In the study by Krant et al. (1968) Maibach and Salmon, 1971 ).
Both Riesco (1970) and Bill and Morgan (1970) have also demonstrated a correlation between cancer curability and the total number of peripheral blood lymphocytes. McCredie. Inch and Sutherland (1973) . in a study of breast cancer, were unable to detect an association between prognosis and lymphocyte count. Our findings support the former view and we have also previously published results showing that lymphocytes from patients with gastrointestinal cancer show a diminished response to phytohaemagglutinin (Lauder and Bone, 1973) . The combination of a reduction in number and functional capacity could reasonably be expected to increase the rate of progression of the neoplasm. Several studies have demonstrated that in a varietv of malignant neoplasms lvmphocytic infiltration of the tumour is associated with longer survival (Black, Opler and Speer, 1.956; Berg. 1959; Lauder and Aherne. 1972) .
The correlation between peripheral blood lymphocyte count and the delayed hypersensitivity response to DNCB is not surprising as delayed hypersensitivity reactions are known to be predominantly mediated via the snmall lymphocyte. Turk and his co-workers have shown that 80O of the cells participating in the skin response to DNCB are lymphocytes and 2000 are macrophages (Turk. Rudner and Heather, 1966; Turk, Heather and Diengdoh. 1966) . Since both the DNCB grade and the lymphocyte count show a statistically significant correlation with the extent of tumour progression, the lymphocyte count and DNCB sensitivity would be expected to be correlated. We have no evidence that the depression in the DH response to DNCB is necessarily directly related to the peripheral blood lymphocyte count and there may be several indirect factors involved. However, Waksman and Arbouys (1960) have shown that the induction of a lymphocytopenia by the administration of a heterologous antilymphocyte antibody before skin testing will inhibit the appearance of some forms of hypersensitivity responses. The biological significance of the degree of responsiveness to DNCB is further supported by the demonstration of Eilber and Morton (1970) of a correlation between poor DNCB response and recurrence of tumours after surgery.
When assessing cell mediated immunity in malignant disease, one must attempt to distinguish between the primary effect of an impaired immune system on the growth of the tumour and the converse secondary effect of advancing tumour growth on the immune system itself. It is possible that depression of the circulating peripheral blood lymphocyte count and cellular immunity are a direct result of increasing tumour mass. For example, patients with terminal disease may be in an advanced state of malnutrition, which has been shown to depress cell mediated immunity (Edelman et al., 1973) . This is a pertinent factor but in this study none of the patients was grossly cachectic and several patients with advanced disease and depressed cellular immunity were in fact obese. Using the closely related sensitizing agent 2.4-dinitro-1-fluorobenzene (DNFB) Levin et al. (1964) concluded that the delayed hypersensitivity response was significantly lower in the cancer patients than in either healthy controls or patients with debilitating non-neoplastic disease.
Other factors capable of causing a depression of lymphocyte production could also be operating. For example, patients under stress have a high circulating corticosteroid level, which in turn can produce thymic atrophy and reduced lymphocyte counts (Valentine, Craddock and Lawrence, 1948) . Widespread metastatic disease could reduce the production of lymphocytes because of bone marrow and lymph node replacement. There may be other factors which act by causing increased destruction of lymphocytes. For example, there could be a toxin liberated by the growing tumour which could destroy lymphocytes or stop their proliferation. Similarly, free antigen may be released from the tumour and be present free in the circulation (Currie, 1973) . Lymphocytes sensitized to this antigen may well, on second contact, become involved in an antigen-antibody reaction with the possibility of lysis of the lymphocytes (Favour, 1957; Dwyer and MacKay, 1970) .
Sensitized lymphocytes could also be removed from the circulation by migration into the neoplasm and attachment to tumour cells. The presence in some tumours of large numbers of lymphocytes has alreadv been mentioned and has been demonstrated by several groups of workers (Black et al., 1956; Berg, 1959; Lauder and Aherne, 1972) . In the gastrointestinal tract lymphocyte infiltration may also reflect nonspecific factors such as ulceration and infection. Zatz, White and Goldstein (1973) have shown that during tumorigenesis in mice significant numbers of circulating lymphocytes were trapped in lymph nodes draining the tumour. This process may have a counterpart in the human.
We may therefore conclude that in patients with malignant disease there may be several factors co-operating to reduce the number of lymphocytes by decreased production or increased destruction and utilization.
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